About the bill
- Full Title
To amend title V of the Federal Food, Drug, and Cosmetic Act to provide for extensions of marketing exclusivity periods for drugs in certain combinations of such drugs, and for other purposes.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
2 cosponsors (2D) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 6502 — 112th Congress: Life-Threatening Diseases Compassion through Combination Therapy Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr6502
“H.R. 6502 — 112th Congress: Life-Threatening Diseases Compassion through Combination Therapy Act of 2012.” www.GovTrack.us. 2012. May 6, 2016 <https://www.govtrack.us/congress/bills/112/hr6502>
|title=H.R. 6502 (112th)
|accessdate=May 6, 2016
|author=112th Congress (2012)
|date=September 21, 2012
|quote=Life-Threatening Diseases Compassion through Combination Therapy Act of 2012